Experimental biomedical research: achievements and future aims


Published: Nov 20, 2017
Keywords:
Research experimental biomedical research laboratory animals three Rs
I. DONTA (Ι. ΔΟΝΤΑ)
Abstract

An invaluable amount of knowledge and enormous progress in the advancement of human health, longevity and quality of life has been achieved by biomedical research throughout the ages. Most of the achievements were accomplished by research on animals and more recently, on laboratory animals. Progress in the production of drugs, vaccines, sera, antibiotics, surgical techniques and materials, diagnostic and therapeutic methods, and many more, was reached by their safety and efficacy testing on laboratory animals, prior to their application on humans. The achievements resulting from this research are applied both in humans and in animals. Experimental biomedical research is currently conducted in animal models of human diseases, invertebrates and with alternative methods to the use of animals. Its future aims are to solve existing and emerging health threats and to increase gene therapy, with the concomitant application of the three Rs principles of animal use - replacement, reduction and refinement.

Article Details
  • Section
  • Special Article
Downloads
Download data is not yet available.
References
Bennett MR (1999) The early history of the synapse: from Plato to Sherrington. Brain Res Bull, 50(2):95-118.
Brenner S (2003) Nobel lecture. Nature's gift to science. Biosci Rep, 23(5-6):225-37.
Commission of the European Communities (2007) Report from the Commission to the Council and the European Parliament. Fifth Report on the Statistics on the Number of Animals used for Experimental and other Scientific Purposes in the Member States of the European Union, COM(2007) 675 final, Brussels, 5.11.2007.
http://eur-lex.europa.eu/LexUriServ/LexUriServ.do ?uri =COM:2007:0675:FIN:EN:PDF (accessed 30.09.2009).
Council of Europe (2006) Revision of Appendix A of the European Convention for the Protection of Vertebrate Animals used for Experimental and other Scientific Purposes (ETS No. 123)
Danilova N, Sakamoto KM, Lin S (2008) Role of p53 family in birth defects: lessons from zebrafish. Birth Defects Res C Embryo Today, 84(3):215-27.
Dominguez LJ, Galioto A, Ferlisi A, Pineo A, Putignano E, Belvedere M et al. (2006) Ageing, lifestyle modifications and cardiovascular disease in developing countries. J Nutr Health Aging, 10(2): 143-9.
Δοντά I (1994) Η επιλογή του καταλληλότερου πειραματόζωου ως πειραματικό πρότυπο. Acta Chir Hellen, 66:28-31.
Evans M (2008) Embryonic stem cells: the mouse source - vehicle for mammalian genetics and beyond (Nobel lecture). Chembiochem, 9(ll):1690-6.
Heeney JL, Dalgleish AG, Weiss RA (2006). Origins of HIV and the evolution of resistance to AIDS. Science, 313(5786):462-466.
Καραγιαννάκος (1994) Η συμβολή των πειραματόζωων στην εξέλιξη της βιοϊατρικής έρευνας. Acta Chir Hellen, 66:23-27.
Loew FM (1988) Animals as beneficiaries of biomedical research originally intended for humans. ILAR News, 30(4): 13-15.
Ning T, Yan X, Lu ZJ, Wang GP, Zhang N, Yang J et al. (2008) Gene therapy in orthotopic lung cancer murine model with angiogenesis inhibitor, endostatin. Hum Gene Ther Oct 21 (Epub ahead of print).
Nobel Foundation (2008) http://nobelprize.org/nobel_prizes/medicine/laureates/1923/index.html (accessed 30.09.2009).
Russell WMS, Burch RL (1959) The Principles of Humane Experimental Technique. Methuen.
Russell WM (1995) The development of the three Rs concept. Altern Lab Anim, 23:298-304.
Segner H (2009) Zebrafish (Danio rerio) as a model organism for investigating endocrine disruption. Comp Biochem Physiol C Toxicol Pharmacol, 148(2);187-95.
Smithies Ο (2008) Turning pages (Nobel lecture). Chembiochem, 9(9): 1342-59.
Written Declaration 40/2007 http://www.europarl.europa.eu/sides/getDoc.do?pubRef = -//EP//NONSGML + PV +20070906 +SIT+DOC+WORD+V0//EN&language=EN (accessed 30.09.2009).
Most read articles by the same author(s)